PYTHIA: A phase II study of palbociclib plus fulvestrant for pretreated patients with ER+/HER2- metastatic breast cancer
D. Zardavas
◽
M. Regan
◽
R. Maibach
◽
B. Ruepp
◽
A. Hiltbrunner
◽
...
2004 ◽
Vol 90
(1)
◽
pp. 36-40
◽
S Gori
◽
M Colozza
◽
A M Mosconi
◽
E Franceschi
◽
C Basurto
◽
...
2019 ◽
Vol 30
(4)
◽
pp. 394-401
Joachim Bischoff
◽
Jana Barinoff
◽
Christoph Mundhenke
◽
Dirk O. Bauerschlag
◽
Serban-Dan Costa
◽
...
2012 ◽
Vol 31
(1)
◽
pp. 152-159
◽
Keun Seok Lee
◽
In Hae Park
◽
Byung-Ho Nam
◽
Jungsil Ro
Ting Li
◽
Biyun Wang
◽
Xichun Hu
◽
Zhonghua Wang
◽
Jian Zhang
◽
...
D Zardavas
◽
M Regan
◽
R Maibach
◽
B Ruepp
◽
A Hiltbrunner
◽
...
F. Zagouri
◽
A. Bamias
◽
P. Papakostas
◽
A. Karadimou
◽
E. Bournakis
◽
...
2006 ◽
Vol 70
(4)
◽
pp. 273-279
◽
S. Kakolyris
◽
K. Kalbakis
◽
A. Potamianou
◽
N. Malamos
◽
L. Vamvakas
◽
...
2004 ◽
Vol 5
(2)
◽
pp. 142-147
◽
Joyce A. O'Shaughnessy
◽
Sasha Vukelja
◽
Thomas Marsland
◽
Gary Kimmel
◽
Suresh Ratnam
◽
...
2002 ◽
Vol 38
(11)
◽
pp. S95
Yeon Hee Park
◽
Tae-Yong Kim
◽
Gun Min Kim
◽
Kyung Hae Jung
◽
Seok Yun Kang
◽
...